Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
30,178 total articles
BMO Capital Markets downgraded Amgen and BioNTech from Outperform to Market Perform, pointing to constrained near-term upside for both firms. For Amgen, loss-of-exclusivity pressures and mixed signals for its obesity candidate weighed on the call. For BioNTech, accelerating erosion of COVID vaccine sales, delayed de-risking for its cancer candidate…
Ipsen shares fell after Barclays downgraded the stock and reduced its price target, highlighting accelerating generic erosion for Somatuline, the risk of a rival CAM2029 showing clinical superiority by late 2026 or early 2027, and a material reinvestment burden tied to later-stage pipeline launches. The downgrade compounded concerns already flagged…
Boston Scientific shares dropped 2.3% in pre-market trading after the company notified investors that the cyberattack discovered on August 25 is now expected to have a material impact on third-quarter and full-year 2026 results, and that it is unlikely to meet previously issued net sales growth and adjusted EPS targets. The announcement represents …
HSBC strategist Max Kettner argues that a series of structural changes since 2022 have left risk assets largely impervious to a succession of negative catalysts. He highlights stronger-than-expected earnings, a positive equity-bond correlation, and an expanded central bank toolkit among the main supports for market resilience, while pointing to the…
BNP Paribas moved Talanx from 'outperform' to 'neutral' following a 23% increase in the insurer's share price since June. The bank reduced its EPS forecasts for 2026 and 2027, set a EUR 120 target price and warned that pricing trends observed in the second quarter could pressure reinsurance combined ratios and commercial top-line growth.
Indian equity benchmarks ended lower on Tuesday, with the Nifty 50 slipping 0.61% to a fresh one-month low and the BSE Sensex falling 0.73%. Losses in the Fast Moving Consumer Goods, Healthcare and Oil & Gas sectors outnumbered gains, while market breadth was negative on both exchanges. Commodity and currency moves included weaker gold futures and …
Goldman Sachs said it is tactically neutral over the coming three months but remains modestly pro-risk across a 12-month horizon. The bank pointed to stronger-than-expected US labor-market data, ongoing procyclical rotations that have slowed since summer, commodity-led returns and a selloff in global sovereign bonds as longer-dated yields climbed. …
Ionis Pharmaceuticals shares plunged in pre-market trading after Novartis disclosed that pelacarsen failed its Phase 3 Lp(a)HORIZON study. Although the drug reduced lipoprotein(a) levels, it did not produce a statistically significant reduction in major cardiovascular events, eliminating the commercial revenue Ionis stood to receive under its 2019 …
Barclays has retained a Neutral rating on the European pharmaceuticals, biotechnology and life sciences sector for 2027 but adopted a more cautious stance compared with its prior positive bias. The bank cited a reduction in expected late-stage pipeline readout potential, marginally slower top-line growth for large-cap names and looming patent expir…
Roivant Sciences stock vaulted in pre-market trading after Pulmovant, a Roivant subsidiary, reported positive topline results from the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease. The data were presented at the European Respiratory Society International Congress 2026 by Professor Marc Hum…
Biohaven Pharmaceutical shares fell in pre-market trade after RBC Capital downgraded the stock and trimmed its price target, with the move spotlighting valuation concerns and the binary clinical risk tied to the company potekalim epilepsy program ahead of a Phase 3 data readout. The downgrade added selling pressure to a stock that had already poste…
Jefferies upgraded Energean from underperform to hold and increased its price target to 800 pence, pointing to a more attractive risk-reward after the stock underperformed this year despite stronger commodity prices. The broker highlighted the company’s Israel-heavy production mix, updated tax modelling that pushed out Sheshinski levy effects and a…
Dyne Therapeutics' stock plunged 31.0% in pre-market trading to $16.76, a fall that market participants usually associate with a material, company-specific development. The move comes as the firm approaches high-stakes regulatory and clinical readouts for its lead programs and after a recent quarterly loss wider than analysts expected.
Inspiration Healthcare Group reported first-half revenue of £22 million, a decline attributed to the absence of one-off export contracts that boosted the prior period. Underlying demand for the company’s neonatal intensive care equipment remained firm, with SLE product sales rising 38% on a like-for-like basis, Airon sales up 40% to £1.6 million an…
Financial Secretary Paul Chan said that additional state-owned infrastructure companies from Central Asia are exploring listings in Hong Kong. He did not identify the firms or give timing. The potential deals are tied to Hong Kong's strategy to broaden its international capital links and deepen its role within the Belt and Road framework, while exi…
The MOEX Russia Index ended the session unchanged, while several large-cap Russian stocks moved in both directions. Rosneft led gainers, while PhosAgro and other miners weighed on the downside. Market breadth favored advancers and the Russian volatility gauge held steady. Commodities and ruble FX pairs moved alongside the session.
Citi's scenario-based analysis finds a probability-weighted winter TTF price near €61/MWh, noticeably below traded October 2026 and front-winter strip levels. The bank warns that the market is attributing a substantial premium to uncertainties around the Strait of Hormuz reopening and the severity of the upcoming winter, while increased participati…
Delegates from 128 states meeting in Geneva agreed on a non-binding document meant to address autonomous weapons systems. The text, reached by consensus, represents a milestone after more than a decade of negotiations but drew criticism from a rights group for weakening earlier language on definitions and civilian protection. Major powers including…
Goldman Sachs has increased its target for the MSCI Asia Pacific Index to 1,120 from 1,080, reflecting higher earnings forecasts led by Korea and Taiwan and driven by stronger technology sector results. The bank remains constructive on Asian equities after a third-quarter pullback but warns of near-term volatility tied to bond yields, Middle East t…
ADARx Pharmaceuticals has filed to go public on the Nasdaq Global Market using the ticker ADRX. The company, which focuses on small interfering RNA therapeutics, reports a pipeline that includes three clinical-stage programs and two advanced preclinical programs. Leading investment banks have been named as underwriters, while the firm did not revea…
Northrop Grumman Corp. received a $508.5 million noncompetitive contract from the U.S. Department of Defense to provide flight test support for ballistic missile targets and integrated logistics for Missile Defense System testing. Separately, the company was awarded a $111.4 million contract, with options that could raise its value to $253.3 millio…
The MOEX Russia Index ended the session higher, rising 1.85% as advances in the Oil & Gas, Mining and Power sectors supported the market. Market breadth was slightly positive, volatility eased, and currency pairs moved modestly against the ruble while gold and crude showed mixed movement in late trading.
Mizuho has designated Snowflake as its top pick in the large-cap software sector after the company reported a notable revenue beat, cited strong demand for new artificial intelligence offerings, and raised its fiscal 2027 product revenue outlook. The bank kept an Outperform rating and increased its price target to $425 from $355, while other broker…
Belgian prosecutors have frozen €65.2 million in connection with a French criminal investigation into suspected tax fraud and money laundering involving McKinsey. The seizure, which represents 96% of the tax shortfall estimated by French authorities, follows a probe opened after a French Senate review of private consultancies' influence on public p…
AI company micro1 Inc. submitted a $12.5 million competing bid for Spirit Aviation Holdings Inc.'s business records, notifying the U.S. Bankruptcy Court for the Southern District of New York that it intends to outbid Google LLC's previously approved $10 million offer from an August 14, 2026 auction. The proposed purchase covers hundreds of millions…
